highest dose of retatrutide in adults with obesity over 104 weeks in the group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide Dosage Guide: What We

The lower availability of MOR in obese individuals may contribute to overeating as a way to compensate for reduced pleasure responses in this system

Patients should contact their healthcare provider if they experience severe or persistent vomiting that prevents adequate fluid or medication intake, as this can lead to dehydration and electrolyte imbalances

19-24 As with exenatide, there is minimal risk of hypoglycemia when used with nonsecretagogue medications

Reported observations have included nausea, diarrhoea, vomiting, and other gastrointestinal effects, most commonly during dose-escalation periods

Information on Peptide Sciences retatrutide and bulk sourcing from China represents the current landscape for those in the research community

The most common side effects are also gastrointestinal (nausea, etc.), especially in the first few months